166 related articles for article (PubMed ID: 8451041)
21. Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma.
Sánchez Parra M; Churruca C; Paredes A; Lacasta A; López de Argumedo G; Alvárez I; Abad T; Egana L; Guimón E; Piera JM
Am J Clin Oncol; 1999 Feb; 22(1):6-7. PubMed ID: 10025370
[TBL] [Abstract][Full Text] [Related]
22. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
[TBL] [Abstract][Full Text] [Related]
25. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
[TBL] [Abstract][Full Text] [Related]
26. Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.
Choksi AJ; Hong WK; Dimery IW; James P; Guillamondegui OM; Byers RM
Cancer; 1988 Mar; 61(5):909-12. PubMed ID: 3338056
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience.
Pai VR; Mazumdar AT; Deshmukh CD; Bakshi AV; Parikh DM; Parikh PM; Mistry RC; Pathak KA
Med Oncol; 2003; 20(1):1-5. PubMed ID: 12665677
[TBL] [Abstract][Full Text] [Related]
28. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin and 5-fluorouracil in recurrent head and neck cancer: results of an outpatient schedule.
Airoldi M; Pedani F; Brando V; Giordano C; Gabriele P
Chemioterapia; 1988 Apr; 7(2):127-9. PubMed ID: 3396116
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of cisplatin and methylglyoxal bis-guanylhydrazone (MGBG) in recurrent squamous cell carcinoma of the head and neck.
Takasugi BJ; Perry DJ; Wheeler RH; Forastiere AA
Am J Clin Oncol; 1986 Aug; 9(4):299-301. PubMed ID: 3751967
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
[TBL] [Abstract][Full Text] [Related]
32. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
[TBL] [Abstract][Full Text] [Related]
34. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
36. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.
Cervellino JC; Araujo CE; Sánchez O; Miles H; Nishihama A
Acta Oncol; 1995; 34(2):257-9. PubMed ID: 7718266
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
39. A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma.
Huang YC; Chang PM; Chen MH; Chu PY; Tzeng CH; Chang SY; Yang MH
Jpn J Clin Oncol; 2011 May; 41(5):630-6. PubMed ID: 21297121
[TBL] [Abstract][Full Text] [Related]
40. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
